Financial Ratios INVO Fertility, Inc.

Equities

IVF

US44984F6097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 07/07/2025 BST			5-day change	1st Jan Change
0.8099 ^USD	-6.26%		-11.76%	-91.67%

06-30	Invo Fertility, Inc. Adds Platelet-Rich Plasma Therapy Capabilities At Wisconsin Fertility Institute	CI
06-25	INVO Fertility, Inc. Receives Notice of Allowance for Modified INVOcell Device Patent	CI

2eb29003c78a0.bG1z-2SlvwZFMEpN9SCjLR114yaWKUO7f6Gnx08P_sM.CR49jxXozX8OW2cAwhLyYShAikjxenTyIOf0rzp5m4IAODKuENLOSXRjAw

Published financial data: INVO FERTILITY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2023	2024
Revenues	3.02M	6.53M
Total Revenues	3.02M	6.53M
Cost of Goods Sold, Total	1.93M	3.66M
Gross Profit	1.09M	2.87M
Selling General & Admin Expenses, Total	7.49M	9.08M
R&D Expenses	166K	490K
Depreciation & Amortization - (IS)	201K	920K
Other Operating Expenses, Total	7.85M	10.49M
Operating Income	-6.77M	-7.61M
Interest Expense, Total	-926K	-1.06M
Net Interest Expenses	-926K	-1.06M
Currency Exchange Gains (Loss)	-420	-
EBT, Excl. Unusual Items	-7.69M	-8.67M
Gain (Loss) On Sale Of Investments	-150K	9.04K
Gain (Loss) On Sale Of Assets	-	-512K
Other Unusual Items	-163K	54.06K
EBT, Incl. Unusual Items	-8.01M	-9.12M
Income Tax Expense	27.79K	-22.91K
Earnings From Continuing Operations	-8.03M	-9.1M
Net Income to Company	-8.03M	-9.1M
Net Income - (IS)	-8.03M	-9.1M
Preferred Dividend and Other Adjustments	-	251K
Net Income to Common Incl Extra Items	-8.03M	-9.35M
Net Income to Common Excl. Extra Items	-8.03M	-9.35M
Per Share Items
Net EPS - Basic	-67.37	-30.19
Basic EPS - Continuing Operations	-67.37	-30.19
Basic Weighted Average Shares Outstanding	119K	310K
Net EPS - Diluted	-67.37	-30.19
Diluted EPS - Continuing Operations	-67.37	-30.19
Diluted Weighted Average Shares Outstanding	119K	310K
Normalized Basic EPS	-40.32	-17.51
Normalized Diluted EPS	-40.32	-17.51
Supplemental Items
EBITDA	-6.57M	-6.69M
EBITA	-6.65M	-6.8M
EBIT	-6.77M	-7.61M
Total Revenues (As Reported)	3.02M	6.53M
Effective Tax Rate - (Ratio)	-0.35	0.25
Current Domestic Taxes	29.74K	-22.91K
Total Current Taxes	29.74K	-22.91K
Deferred Domestic Taxes	-1.95K	-
Total Deferred Taxes	-1.95K	-
Normalized Net Income	-4.81M	-5.42M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	166K	490K
Stock-Based Comp., Other (Total)	1.57M	1.77M
Total Stock-Based Compensation	1.57M	1.77M

Fiscal Period: December	2023	2024
Assets
Cash And Equivalents	232K	741K
Total Cash And Short Term Investments	232K	741K
Accounts Receivable, Total	141K	175K
Total Receivables	141K	175K
Inventory	265K	220K
Prepaid Expenses	622K	182K
Total Current Assets	1.26M	1.32M
Gross Property Plant And Equipment	4.42M	3.09M
Accumulated Depreciation	-234K	-336K
Net Property Plant And Equipment	4.19M	2.75M
Long-term Investments	3.09M	741K
Goodwill	5.88M	23.54M
Other Intangibles, Total	4.09M	18.1M
Total Assets	18.51M	46.45M
Liabilities
Accounts Payable, Total	2.33M	5.71M
Accrued Expenses, Total	722K	2.12M
Short-term Borrowings	880K	880K
Current Portion of Long-Term Debt	630K	5.46M
Current Portion of Leases	182K	239K
Unearned Revenue Current, Total	409K	602K
Other Current Liabilities	2.85M	2.91M
Total Current Liabilities	8M	17.93M
Long-Term Debt	1.25M	1.13M
Long-Term Leases	3.36M	2.19M
Other Non Current Liabilities	5M	12.46M
Total Liabilities	17.61M	33.7M
Preferred Stock Non Redeemable	6M	30.38M
Total Preferred Equity	6M	30.38M
Common Stock, Total	20	37
Additional Paid In Capital	52.71M	49.54M
Retained Earnings	-57.82M	-67.16M
Comprehensive Income and Other	229	-
Total Common Equity	-5.11M	-17.63M
Total Equity	893K	12.75M
Total Liabilities And Equity	18.51M	46.45M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	1.07M
ECS Total Common Shares Outstanding	373K	373K
Book Value / Share	-13.69	-47.26
Tangible Book Value	-15.08M	-59.27M
Tangible Book Value Per Share	-40.43	-158.88
Total Debt	6.3M	9.9M
Net Debt	6.07M	9.15M
Account Code - Inventory Valuation	-	5
Inventories - Raw Materials, Total	53.48K	53.54K
Inventories - Finished Goods, Total	211K	166K
Machinery, Total	522K	706K
Full Time Employees	-	33
Part Time Employees	-	4

Fiscal Period: December	2023	2024
Net Income	-8.03M	-9.1M
Depreciation & Amortization - CF	80.32K	102K
Amortization of Goodwill and Intangible Assets - (CF)	121K	818K
Depreciation & Amortization, Total	201K	920K
Amortization of Deferred Charges, Total - (CF)	720K	622K
(Gain) Loss From Sale Of Asset	-	512K
(Gain) Loss on Sale of Investments - (CF)	89.79K	-
(Income) Loss On Equity Investments - (CF)	60.27K	-9.04K
Stock-Based Compensation (CF)	1.57M	1.77M
Other Operating Activities, Total	163K	445K
Change In Accounts Receivable	-63.4K	-34.33K
Change In Inventories	-905	44.74K
Change In Accounts Payable	925K	1.35M
Change in Unearned Revenues	289K	194K
Change In Deferred Taxes	-1.95K	-
Change in Other Net Operating Assets	-676K	308K
Cash from Operations	-4.76M	-2.97M
Capital Expenditure	-445K	-184K
Sale of Property, Plant, and Equipment	-	75.59K
Cash Acquisitions	-2.04M	472K
Investment in Marketable and Equity Securities, Total	-8.45K	-
Cash from Investing	-2.49M	364K
Short Term Debt Issued, Total	100K	-
Long-Term Debt Issued, Total	3.06M	1.34M
Total Debt Issued	3.16M	1.34M
Long-Term Debt Repaid, Total	-1.5M	-934K
Total Debt Repaid	-1.5M	-934K
Issuance of Common Stock	5.73M	1.07M
Issuance of Preferred Stock	-	1.64M
Cash from Financing	7.39M	3.12M
Net Change in Cash	142K	509K
Supplemental Items
Cash Interest Paid	9.64K	215K
Levered Free Cash Flow	-	3.2M
Unlevered Free Cash Flow	-	3.24M
Change In Net Working Capital	-	-5.49M
Net Debt Issued / Repaid	1.66M	410K

Fiscal Period: December	2023	2024
Profitability
Return on Assets	-	-14.65
Return on Total Capital	-	-31.9
Return On Equity %	-	-133.37
Return on Common Equity	-	82.22
Margin Analysis
Gross Profit Margin %	35.96	44
SG&A Margin	247.85	138.99
EBITDA Margin %	-217.38	-102.48
EBITA Margin %	-220.04	-104.05
EBIT Margin %	-224.04	-116.56
Income From Continuing Operations Margin %	-266	-139.25
Net Income Margin %	-266	-139.25
Net Avail. For Common Margin %	-266	-143.09
Normalized Net Income Margin	-159.19	-82.96
Levered Free Cash Flow Margin	-	48.95
Unlevered Free Cash Flow Margin	-	49.53
Asset Turnover
Asset Turnover	-	0.2
Fixed Assets Turnover	-	1.88
Receivables Turnover (Average Receivables)	-	41.42
Inventory Turnover (Average Inventory)	-	15.11
Short Term Liquidity
Current Ratio	0.16	0.07
Quick Ratio	0.05	0.05
Operating Cash Flow to Current Liabilities	-0.59	-0.17
Days Sales Outstanding (Average Receivables)	-	8.84
Days Outstanding Inventory (Average Inventory)	-	24.23
Average Days Payable Outstanding	-	407.45
Cash Conversion Cycle (Average Days)	-	-374.38
Long Term Solvency
Total Debt/Equity	705.81	77.63
Total Debt / Total Capital	87.59	43.7
LT Debt/Equity	516.36	26.03
Long-Term Debt / Total Capital	64.08	14.65
Total Liabilities / Total Assets	95.18	72.56
EBIT / Interest Expense	-7.31	-7.21
EBITDA / Interest Expense	-7.09	-6.34
(EBITDA - Capex) / Interest Expense	-7.57	-6.51
Total Debt / EBITDA	-0.96	-1.48
Net Debt / EBITDA	-0.92	-1.37
Total Debt / (EBITDA - Capex)	-0.9	-1.44
Net Debt / (EBITDA - Capex)	-0.87	-1.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	116.25
Gross Profit, 1 Yr. Growth %	-	164.63
EBITDA, 1 Yr. Growth %	-	1.95
EBITA, 1 Yr. Growth %	-	2.25
EBIT, 1 Yr. Growth %	-	12.51
Earnings From Cont. Operations, 1 Yr. Growth %	-	13.21
Net Income, 1 Yr. Growth %	-	13.21
Normalized Net Income, 1 Yr. Growth %	-	12.7
Diluted EPS Before Extra, 1 Yr. Growth %	-	-55.18
Accounts Receivable, 1 Yr. Growth %	-	24.43
Inventory, 1 Yr. Growth %	-	-16.92
Net Property, Plant and Equip., 1 Yr. Growth %	-	-34.29
Total Assets, 1 Yr. Growth %	-	151
Tangible Book Value, 1 Yr. Growth %	-	293.03
Common Equity, 1 Yr. Growth %	-	245.15
Cash From Operations, 1 Yr. Growth %	-	-37.45
Capital Expenditures, 1 Yr. Growth %	-	-58.69